Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREFor the vaccination of healthy chickens against disease caused by Avibacterium paragallinarum (CORYZA).
LEARN MOREFor treatment of respiratory disease associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Salmonella Choleraesuis, Streptococcus…
LEARN MOREFor treatment of BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and bovine interdigital phlegmon associated with…
LEARN MORE